Bentz M, Werner C A, Döhner H, Joos S, Barth T F, Siebert R, Schröder M, Stilgenbauer S, Fischer K, Möller P, Lichter P
Medizinische Klinik, Universität Heidelberg, Germany.
Blood. 1996 Aug 15;88(4):1437-44.
The classical follicular variant of follicle center lymphoma (FCL-fo) is associated with the chromosomal translocation t(14;18)(q32;q21). However, the sole presence of this translocation is not sufficient for malignant transformation, as demonstrated by experiments in a transgenic mouse model. Most of the secondary changes, which play a central role in tumor development and progression and which are presumed to be of prognostic value, are gains and losses of chromosomal material. We analyzed 28 FCL-fo patients using comparative genomic hybridization (CGH). The most frequent imbalances were gains on chromosomes X, 7, 8, 12, and 18 as well as losses of material on chromosome arm 6q. For chromosomes X, 8, 12, and 18, the CGH data allowed further narrowing of the relevant subregions. In addition, novel high-level DNA amplifications were identified in five instances mapping to chromosome bands 1p36, 6p21, 8q24 (2 patients), and 12q13-14. Previously, such amplifications have been identified very rarely in lymphomas. In the 2 patients with amplifications mapping to chromosomal band 8q24, involvement of the MYC proto-oncogene in the amplification unit was demonstrated by Southern blot analysis. These data provide further entry points for studies to identify genes relevant for tumor progression in FCL-fo.
滤泡中心淋巴瘤的经典滤泡变异型(FCL-fo)与染色体易位t(14;18)(q32;q21)相关。然而,正如转基因小鼠模型实验所表明的,仅存在这种易位不足以导致恶性转化。大多数在肿瘤发生和进展中起核心作用且被认为具有预后价值的继发性改变是染色体物质的增减。我们使用比较基因组杂交(CGH)分析了28例FCL-fo患者。最常见的失衡是X、7、8、12和18号染色体的增益以及6q染色体臂物质的缺失。对于X、8、12和18号染色体,CGH数据使相关亚区域进一步缩小。此外,在5例病例中鉴定出了新的高水平DNA扩增,其定位于染色体带1p36、6p21、8q24(2例患者)和12q13-14。此前,这种扩增在淋巴瘤中很少被发现。在2例扩增定位于染色体带8q24的患者中,通过Southern印迹分析证实了MYC原癌基因参与了扩增单元。这些数据为研究鉴定FCL-fo中与肿瘤进展相关的基因提供了进一步的切入点。